Others

1st ICMR Annual Clinical Trial Meet 2026 highlights India’s emerging leadership in integrative medicine research

ICMR launches report to strengthen First-in-Human Phase 1 clinical trials in India

Operational guidelines for single ethics review of multicentre research launched

Experts deliberate on strengthening India’s clinical research and regulatory ecosystem

New Delhi (thestates.news) | The Indian Council of Medical Research successfully organised the “1st ICMR Annual Clinical Trial Meet 2026” on May 20, 2026, under the theme “International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials.” The national-level event served as a significant platform for deliberations on strengthening India’s clinical trial ecosystem and advancing evidence-based integrative medicine research in the country.

The meet brought together policymakers, scientists, clinicians, researchers, regulatory authorities and experts from diverse fields to discuss emerging opportunities, ethical frameworks, regulatory pathways and innovations in clinical research.

The programme was graced by Prof. (Dr.) V. K. Paul, Dr. Rajiv Bahl and Vaidya Rajesh Kotecha along with eminent experts and stakeholders from the healthcare and scientific community.

Addressing the gathering, the dignitaries highlighted the need for robust clinical research systems, ethical governance and scientific validation of integrative healthcare practices to address emerging public health challenges and strengthen healthcare delivery mechanisms in the country.

One of the major highlights of the event was the presentation of findings from the ICMR-CCRAS multicentric Phase III Randomized Controlled Trial (RCT) on Iron Deficiency Anaemia. The study evaluated integrative approaches for managing anaemia, a major public health concern in India.(s-pib)